Sample digital edition
Register for a free digital subscriptionVol. 11, No. 1
January 2002
A "health care fed" that oversees standards and rules on costs for new medications might be just what the industry needs. Three respected health care policy experts explain why.
Last year, nearly 3,300 physicians had their licenses revoked for any number of reasons. New programs hold the promise of putting them back on their professional feet.
Q&A: A Conversation with Peter Lee
Yes, says the CEO of the Pacific Business Group on Health, consumers will gain more leverage in the years to come. That doesn't mean defined contribution plans will flower, however.
When To Deny One Pediatric Medication
Appropriate application of criteria for the use of palivizumab shows that managed care companies can save $6,000 per case with no additional risk to patients.
Change or die.
News and Commentary
To Save Money, Employers Reduce Number of Plans Offered to Workers
NCQA Launches Effort To Accredit DM Programs
COBRA's prohibitive costs prevent access to pharmacy [charts]
1-Year Delay Near In Implementation Of HIPAA Rules
AMA Lobbies To Give Docs Union Rights
Drugstore Info Could Be Used To Thwart Terror
Headlines On Deadline ...
What constitutes a kickback?
Two views on class-action suits.
Case for national medical ID cards.
PCP salaries higher down South.
Measuring Sept. 11's effects.
Struggling to keep pharmacy benefit.